Sponsored by:

Molecular Imaging: Page 468

GE bullish on BGO PET crystal technology
By AuntMinnie.com staff writers
Despite a slowdown in equipment purchasing caused by the Deficit Reduction Act (DRA) of 2005, GE Healthcare will continue to pursue long-term sourcing agreements with its bismuth germinate (BGO) crystal suppliers for its PET and PET/CT systems, the Discovery LS, Discovery ST, and Discovery STE.
March 20, 2007
Tyco Healthcare names Wright as pharma/imaging president
Tyco Healthcare, a St. Louis-based subsidiary of industrial conglomerate Tyco International of Pembroke, Bermuda, has appointed Timothy Wright as president of its pharmaceutical and imaging solutions business units.
March 19, 2007
IBA increases sales and profit in 2006
By AuntMinnie.com staff writers
Buoyed by a 44% hike in European sales for its radioisotopes, nuclear medicine products firm Ion Beam Applications (IBA) posted sales growth and greater profits in 2006.
March 14, 2007
Eckert & Ziegler ends deal with RadQual
By AuntMinnie.com staff writers
Radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products said that RadQual has informed the company that it has now developed its own process to manufacture gamma camera flood sources and that it is no longer using Eckert & Ziegler technology.
March 14, 2007
Molecular markers: Putting too fine a point on DCIS?
By Shalmali Pal
KEY LARGO, FL - The great promise of genetic testing and molecular markers may be all the rage right now, but that doesn't mean good old-fashioned imaging and pathology will fall by the wayside. At least that's the opinion of an expert panel at the Breast Course 2007 this week that discussed the role genetic information will play for assessing ductal carcinoma in situ (DCIS).
March 14, 2007
SoftScan clinical trial moves ahead
By AuntMinnie.com staff writers
KEY LARGO, FL - Optical molecular imaging developer ART Advanced Research Technologies has enrolled 320 patients in phase III of a 950-person clinical trial for SoftScan, currently under way at several Canadian institutions.
March 11, 2007
PET/CT moves to prime time as first-line tool for lung cancer diagnosis
By Jonathan S. Batchelor
VIENNA - A study unveiled by researchers from Spain at this week's European Congress of Radiology (ECR) suggests that the current imbroglio swirling around CT screening may be only Sturm und Drang, at least when compared to the use of integrated PET/CT for lung cancer diagnosis. PET/CT has several advantages over PET and CT for diagnosing lung cancer, according to the group.
March 9, 2007
Italung-CT results show efficacy of lung cancer screening
By Eric Barnes
VIENNA - The first results of a sizeable Italian multicenter screening trial suggest once again that CT screening of smokers is effective in finding lung cancer in time to cure it. Presented at the European Congress of Radiology (ECR), the results are among the first of several randomized trials undertaken to assess the efficacy of CT lung cancer screening.
March 8, 2007
Automated emission correction shows potential for cardiac PET/CT
By Jonathan S. Batchelor
The CT portion of a hybrid PET/CT scan is commonly, and successfully, used for attenuation correction in these studies. Because acquisition during these exams is not simultaneous for each modality, nor is temporal resolution equivalent, the potential for data misregistration exists. Researchers from Germany have developed a method of automated emission correction that shows promise for image registration between the technologies, especially for cardiac studies.
March 8, 2007
2007 03 05 11 45 53 706
SNMTS disburses scholarships
By AuntMinnie.com staff writers
The SNM Technologist Section (SNMTS) recently bestowed $50,000 in Paul Cole and Mickey Williams Minority Student scholarships for molecular imaging/nuclear medicine technologist students during its Mid-Winter Educational Symposium held in San Antonio.
March 5, 2007
VisEn, Merck to develop molecular imaging agents
By AuntMinnie.com staff writers
Optical imaging developer VisEn Medical has entered a multiyear joint research and development program with Merck to create and apply a range of fluorescence imaging agents for real-time imaging of key disease biomarkers in vivo.
March 5, 2007
AuntMinnie.com Molecular Imaging Insider
By Jonathan S. Batchelor
March 4, 2007
Previous Page
Page 468 of 615
Next Page